Elevation Oncology, Inc.
ELEV
$0.381
-$0.0039-1.01%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -36.17% | 18.98% | -23.13% | 2.30% | -35.55% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 25.00% | -60.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -5.64% | 10.24% | 1.61% | -53.27% | 12,435.71% |
| Change in Net Operating Assets | 195.11% | -118.37% | 154.26% | 338.84% | 85.86% |
| Cash from Operations | -24.59% | -21.71% | -2.16% | 14.31% | 21.39% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 107.17% | 499.16% | 92.37% | -281.93% | 215.55% |
| Cash from Investing | 107.17% | 499.16% | 92.37% | -281.93% | 215.55% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | -99.92% | -51.63% | -- |
| Repurchase of Common Stock | -325.00% | -100.00% | 87.50% | 38.46% | -1,200.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | 86.67% | -- |
| Cash from Financing | -325.00% | -140.00% | -99.93% | -51.46% | 1,512,600.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 774.01% | 111.22% | 63.94% | -175.37% | 835.82% |